Cal. Code Regs. Tit. 17, § 10376 - Drug and Device Manufacturing Licenses
(a) The fee for a manufacturer's license as
required by Sections
26685
and
26688
of the Health and Safety Code is $200.00 and will cover a period of 12 months.
The license is not transferable and will not be prorated.
(b) Manufacturers of human prescription drugs
shall pay an additional license fee of $100.00 per year, plus the fingerprint
processing fee charged by the California Department of Justice.
(c) Application for Drug Manufacturing
License shall be made on State Department of Health form #EH-52 (Rev. 4/93).
Applications for a Device Manufacturing License shall be made on State
Department of Health form #EH-72.
(d) Applications for a Drug Manufacturing
License shall include the following information on or attached to the
application form:
(1) The name of the license
applicant, and the full business address and telephone number of the
manufacturing facility;
(2) All
trade or business names used by the license applicant;
(3) Name(s) of the person(s) in charge of
manufacturing;
(4) Name, address
and telephone number of the person responsible for correspondence;
(5) The type of ownership or operation (for
example, partnership, association, corporation, or individual/sole
proprietorship);
(6) The name(s) of
the owner and/or operator of the license applicant, including:
(A) If an individual, the name of the
individual; if a sole proprietorship, the name of the sole proprietor and the
name of the business entity;
(B) If
a partnership or other unincorporated association, the name of each partner or
member, and name of the partnership or association;
(C) If a corporation, the corporate name, and
the state of incorporation, the name and title of each corporate officer and
director; and
(D) The name of each
person holding more than 5 percent equity, or debt liability of the
applicant.
(7) Types of
products to be manufactured;
(8)
Type of processing to be utilized;
(9) Signature of license applicant under
penalty of perjury affirming that the information in the application is true
and accurate;
(10) Printed name and
title of the individual signing the application;
(11) Date application was signed;
and
(12) For human prescription
drug manufacturers only:
(A) properly
completed Disclosure Statement (form #EH-53 (rev. 4/93)), two properly
completed fingerprint cards, and fingerprint processing fee for each person in
charge of manufacturing and each person whose name is required to be included
in the license application under Paragraphs (d)(6)(A) through (d)(6)(C).
However, where the license applicant is a corporation, partnership, or other
business association and the total number of partners, members, or corporate
officers, directors, and shareholders (as the case may be) exceeds five, the
application shall so state, and the documents and fee described in this
Paragraph shall only be submitted for each person in charge of manufacturing,
and
1. For corporations: of the corporate
officers who reside in California, or who reside outside California, but are
involved in the routine operations of the manufacturing facility, the documents
and fee shall be submitted for each of the five highest ranking officers in
this group, and
2. For
partnerships, joint ventures, and similar business association: of the partners
or members who reside in California, or who reside outside California, but are
involved in the routine operations of the manufacturing facility, the documents
and fee shall be submitted for each of the five persons in this group who own
the largest interests in the applicant entity.
(B) Fingerprint cards and fingerprint
processing fee shall only be submitted once for each person. If there is a
change of any person in charge of manufacturing or any person occupying a
position listed in Paragraphs (d)(6)(A) through (d)(6)(C), fingerprint cards
and processing fee shall be submitted for each new or additional
person.
(C) Other persons listed in
Paragraph (d)(6) may be required by the Department to submit the documents
described in this Paragraph as necessary to determine the qualifications of the
applicant.
(e)
Within 30 calendar days of receipt of a drug manufacturing license application,
the Department shall inform the applicant in writing that it is either complete
and accepted for filing or that the application is deficient and what specific
information or documentation is required to complete the application. An
application is considered complete when all information, documents, and fees
required in this Section have been received by the Department.
(f) Within 240 calendar days from the date of
filing of a completed drug manufacturing license application, the Department
shall inform the applicant in writing of its decision regarding a drug
manufacturing license application. The median time for the Department to
process a drug manufacturing license application from acceptance of the initial
application to the final license decision has been 29 calendar days; the
minimum time was one calendar day; the maximum time was 919 calendar
days.
Notes
2. Certificate of Compliance--section 11422.1, Gov. Code, filed 7-29-69 (Register 69, No. 31).
3. Amendment filed 7-21-76; effective thirtieth day thereafter (Register 76, No. 30).
4. Amendment of section heading, new subsection (b) and renumbering and amendment of following paragraph and repealer of subsections (c)-(d) and new subsections (d)-(f) and amendment of NOTE filed 9-25-92 as an emergency; operative 9-25-92 (Register 92, No. 39). A Certificate of Compliance must be transmitted to OAL 1-25-93 or emergency language will be repealed by operation of law on the following day.
5. Amendment refiled 1-20-93 as an emergency; operative 1-26-93 (Register 93, No. 4). A Certificate of Compliance must be transmitted to OAL 5-26-93 or emergency language will be repealed by operation of law on the following day.
6. Editorial correction of HISTORY 5. (Register 93, No. 20).
7. Certificate of Compliance as to 1-20-93 order including amendment of subsections (c) and (d)(12)(A), and repealer and new subsections (d)(12)(A)1.-2. transmitted to OAL 5-26-93 and filed 7-8-93 (Register 93, No. 28).
Note: Authority cited: Section 15376, Government Code and Sections 102, 208, 26202, 26209 and 26688, Health and Safety Code. Reference: Sections 26685, 26687, 26688 and 26689, Health and Safety Code.
2. Certificate of Compliance -section 11422.1, Gov. Code, filed 7-29-69 (Register 69, No. 31).
3. Amendment filed 7-21-76; effective thirtieth day thereafter (Register 76, No. 30).
4. Amendment of section heading, new subsection (b) and renumbering and amendment of following paragraph and repealer of subsections (c)-(d) and new subsections (d)-(f) and amendment of N ote filed 9-25-92 as an emergency; operative 9-25-92 (Register 92, No. 39). A Certificate of Compliance must be transmitted to OAL 1-25-93 or emergency language will be repealed by operation of law on the following day.
5. Amendment refiled 1-20-93 as an emergency; operative 1-26-93 (Register 93, No. 4). A Certificate of Compliance must be transmitted to OAL 5-26-93 or emergency language will be repealed by operation of law on the following day.
6. Editorial correction of History 5. (Register 93, No. 20).
7. Certificate of Compliance as to 1-20-93 order including amendment of subsections (c) and (d)(12)(A), and repealer and new subsections (d)(12)(A)1.-2. transmitted to OAL 5-26-93 and filed 7-8-93 (Register 93, No. 28).
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.